GEDULIN; Bronislava

Patent Applications and Registrations

Patent applications and USPTO patent grants for GEDULIN; Bronislava.The latest application filed is for "bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases".

Company Profile

10.27.49

GEDULIN; Bronislava - Del Mar CA
GEDULIN; Bronislava - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20220265649 - GEDULIN; Bronislava ; et al.	2022-08-25
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases Grant 11,376,251 - Gedulin , et al. July 5, 2	2022-07-05
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions Grant 11,260,053 - Gedulin , et al. March 1, 2	2022-03-01
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20220023296 - GEDULIN; Bronislava ; et al.	2022-01-27
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases Grant 11,229,661 - Gedulin , et al. January 25, 2	2022-01-25
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20200246366 - Kind Code	2020-08-06
Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver Disease App 20200207797 - GEDULIN; Bronislava ; et al.	2020-07-02
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20200069715 - GEDULIN; Bronislava ; et al.	2020-03-05
Bile acid recycling inhibitors for treatment of obesity and diabetes Grant 10,555,950 - Young , et al. Feb	2020-02-11
Bile acid recycling inhibitors for treatment of pediatric cholestatic liver diseases Grant 10,512,657 - Gedulin , et al. Dec	2019-12-24
Bile Acid Recycling Inhibitors And Satiogens For Treatment Of Diabetes, Obesity, And Inflammatory Gastrointestinal Conditions App 20190247390 - GEDULIN; Bronislava ; et al.	2019-08-15
Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver Disease App 20190169217 - GEDULIN; Bronislava ; et al.	2019-06-06
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions Grant 10,251,880 - Gedulin , et al.	2019-04-09
Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions Grant 10,188,646 - Gedulin , et al. Ja	2019-01-29
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof Grant 10,028,952 - Young , et al. July 24, 2	2018-07-24
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20170368085 - Gedulin; Bronislava ; et al.	2017-12-28
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20160310518 - Gedulin; Bronislava ; et al.	2016-10-27
Methods Of Treating Diabetes Or Obesity Using Bile Acids, Bile Salts, And Mimics Thereof App 20160235745 - Young; Andrew A. ; et al.	2016-08-18
Bile Acid Recycling Inhibitors For Treatment Of Obesity And Diabetes App 20160220577 - YOUNG; Andrew A. ; et al.	2016-08-04
Methods of treating diabetes or obesity using bile acids, bile salts, and mimics thereof Grant 9,345,715 - Young , et al. May 24, 2	2016-05-24
Bile acid recycling inhibitors for treatment of obesity and diabetes Grant 9,339,480 - Young , et al. May 17, 2	2016-05-17
Bile Acid Recycling Inhibitors For Treatment Of Gastrointestinal Infections App 20150119345 - GEDULIN; Bronislava ; et al.	2015-04-30
Bile Acid Recycling Inhibitors And Satiogens For Treatment Of Diabetes, Obesity, And Inflammatory Gastrointestinal Conditions App 20150087642 - GEDULIN; Bronislava ; et al.	2015-03-26
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility App 20150080307 - YOUNG; Andrew A. ; et al.	2015-03-19
Bile Acid Recycling Inhibitors For Treatment Of Hypercholemia And Cholestatic Liver Disease App 20140323412 - Gedulin; Bronislava ; et al.	2014-10-30
Bile Acid Recycling Inhibitors For Treatment Of Primary Sclerosing Cholangitis And Inflammatory Bowel Disease App 20140275090 - GEDULIN; Bronislava ; et al.	2014-09-18
Bile Acid Recycling Inhibitors For Treatment Of Barrett's Esophagus And Gastroesophageal Reflux Disease App 20140271734 - GEDULIN; Bronislava ; et al.	2014-09-18
Bile Acid Recycling Inhibitors For Treatment Of Pediatric Cholestatic Liver Diseases App 20140243281 - Gedulin; Bronislava ; et al.	2014-08-28
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases App 20130338093 - GEDULIN; Bronislava ; et al.	2013-12-19
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility App 20130331322 - Young; Andrew A. ; et al.	2013-12-12
Compositions Containing Satiogens and Methods of Use App 20130190281 - Young; Andrew A. ; et al.	2013-07-25
Method of reducing plasma amylase and/or plasma lipase in patients with pancreatitis Grant 8,481,490 - Tatarkiewicz , et al. July 9, 2	2013-07-09
Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease App 20130108573 - GEDULIN; Bronislava ; et al.	2013-05-02
Bile Acid Recycling Inhibitors for Treatment of Pediatric Cholestatic Liver Diseases App 20130109671 - GEDULIN; Bronislava ; et al.	2013-05-02
Methods and Apparatus for Treating Obesity and Diabetes App 20130090590 - YOUNG; Andrew A. ; et al.	2013-04-11
Bile Acid Recycling Inhibitors And Satiogens For Treatment Of Diabetes, Obesity, And Inflammatory Gastrointestinal Conditions App 20130059807 - Gedulin; Bronislava ; et al.	2013-03-07
Bile Acid Recycling Inhibitors for Treatment of Pancreatitis App 20130034536 - GEDULIN; Bronislava	2013-02-07
Exendin And Exendin Agonists For Eating Disorders App 20130023470 - Young; Andrew A. ; et al.	2013-01-24
Methods of treating diabetes and/or obesity using an enteroendocrine peptide secretion enhancing agent Grant 8,318,663 - Young , et al. November 27, 2	2012-11-27
Glp-1 Receptor Agonists To Treat Pancreatitis App 20120295850 - Tatarkiewicz; Krystyna ; et al.	2012-11-22
Exendin and exendin agonists for eating disorders Grant 8,288,338 - Young , et al. October 16, 2	2012-10-16
Methods of using GLP-1 receptor agonists to treat pancreatitis Grant 8,263,554 - Tatarkiewicz , et al. September 11, 2	2012-09-11
Bile Acid Recycling Inhibitors For Treatment Of Obesity And Diabetes App 20120157399 - Young; Andrew A. ; et al.	2012-06-21
Treatment of pancreatitis with amylin Grant 8,168,233 - Gedulin , et al. May 1, 2	2012-05-01
Exendins And Exendin Agonist Analogs To Regulate Gastrointestinal Motility App 20120004168 - Young; Andrew A. ; et al.	2012-01-05
Glp-1 Receptor Agonists To Treat Pancreatitis App 20110306549 - Tatarkiewicz; Krystyna ; et al.	2011-12-15
Bile Acid Recycling Inhibitors And Satiogens For Treatment Of Diabetes, Obesity, And Inflammatory Gastrointestinal Conditions App 20110294767 - Gedulin; Bronislava ; et al.	2011-12-01
Exendins and exendin agonist analogs to regulate gastrointestinal motility Grant 8,026,210 - Young , et al. September 27, 2	2011-09-27
Treatment of Obesity or Diabetes with Bile Acid Sequestrants App 20110152204 - GEDULIN; Bronislava ; et al.	2011-06-23
Exendin and Exendin Agonists for Eating Disorders App 20110034377 - YOUNG; ANDREW A. ; et al.	2011-02-10
Exendins and exendin agonists for weight reduction and obesity Grant 7,741,269 - Young , et al. June 22, 2	2010-06-22
Bile Acid Recycling Inhibitors For Treatment Of Obesity And Diabetes App 20100130472 - YOUNG; Andrew A. ; et al.	2010-05-27
Compositions Containing Satiogens And Methods Of Use App 20100130426 - YOUNG; Andrew A. ; et al.	2010-05-27
Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility App 20090163423 - Young; Andrew A. ; et al.	2009-06-25
Exendin pharmaceutical compositions Grant 7,521,423 - Young , et al. April 21, 2	2009-04-21
Methods for glucagon suppression using modified exendins Grant 7,407,932 - Young , et al. August 5, 2	2008-08-05
Methods for Treating or Ameliorating Ghrelin-Associated Diseases and Disorders App 20070275877 - Baron; Alain ; et al.	2007-11-29
Pharmaceutical compositions containing exendins Grant 7,297,761 - Beeley , et al. November 20, 2	2007-11-20
Methods for glucagon suppression using modified exendins App 20070037750 - Young; Andrew A. ; et al.	2007-02-15
Methods for glucagon suppression using modified exendins Grant 7,153,825 - Young , et al. December 26, 2	2006-12-26
Method for treating or preventing gastritis using amylin or amylin agonists Grant 7,101,853 - Young , et al. September 5, 2	2006-09-05
Prevention and/or treatment of inflammatory bowel disease using pyy or agonists thereof App 20060122106 - Gedulin; Bronislava ; et al.	2006-06-08
Pharmaceutical compositions containing exendins App 20050215469 - Beeley, Nigel Robert Arnold ; et al.	2005-09-29
Methods for glucagon suppression using modified exendins App 20050171019 - Young, Andrew A. ; et al.	2005-08-04
Treatment of pancreatitis with amylin App 20050070472 - Gedulin, Bronislava ; et al.	2005-03-31
Methods for glucagon suppression Grant 6,872,700 - Young , et al. March 29, 2	2005-03-29
Exendin formulations for weight reduction App 20050043238 - Young, Andrew A. ; et al.	2005-02-24
Methods for regulating gastrointestinal motility Grant 6,858,576 - Young , et al. February 22, 2	2005-02-22
Exendin pharmaceutical compositions App 20040266692 - Young, Andrew A. ; et al.	2004-12-30
Method For Preventing Gastritis Using Amylin Or Amylin Agonists App 20020010133 - YOUNG, ANDREW A. ; et al.	2002-01-24

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.